Beta Bionics (BBNX) Change in Receivables (2024 - 2026)

Beta Bionics has disclosed Change in Receivables across 3 years of filings, most recently posting $2.3 million for Q2 2026.

• In Q2 2026, Change in Receivables fell 0.69% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $6.7 million (up 172.82% YoY), while the FY2025 annual figure was $5.2 million, down 32.24% from the prior year.
• Change in Receivables came in at $2.3 million for Q2 2026 at Beta Bionics, up from -$1.4 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $5.6 million in Q4 2025 to a low of -$2.9 million in Q1 2025.
• Average Change in Receivables over 3 years is $1.4 million, with a median of $2.1 million recorded in 2024.
• The largest YoY upside for Change in Receivables was 111.23% in 2025 against a maximum downside of 253.08% in 2025.
• Over 3 years, Change in Receivables stood at $4.6 million in 2024, then rose by 22.75% to $5.6 million in 2025, then plunged by 58.55% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were $2.3 million in Q2 2026, -$1.4 million in Q1 2026, and $5.6 million in Q4 2025.